Skip to main content

Table 1 Categorization of patients (n = 150) based on response grade and drug overuse of triptans

From: Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine

 

Patients no.

Therapy response grade

 0–25% (class 1)

38

 25–50% (class 2)

29

 50–75% (class 3)

35

 75–100% (class 4)

48

Drug overuse

 Yes

75

 No

51

 Not assigned

24